Author(s):
Nagaraju Bandaru, Chandrasekhar Komavari, Uma Sankar Gorla, GSN Koteswarao, Umasankar Kulandaivelu, A. Ankarao
Email(s):
bnagaraju@kluniversity.in
DOI:
10.5958/0974-360X.2020.00481.3 
Address:
Nagaraju Bandaru1*, Chandrasekhar Komavari2, Uma Sankar Gorla1, GSN Koteswarao1, Umasankar Kulandaivelu1, A. Ankarao1
1Department of Pharmacology, College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur, Andhra Pradesh, India - 522502.
2Department of Pharmacology, Shri Vishnu College of Pharmacy, Bhimavaram, Andhra Pradesh - 534202.
*Corresponding Author
Published In:
Volume - 13,
Issue - 6,
Year - 2020
ABSTRACT:
Background: Alzheimer disease (AD) is a progressive dementia affecting a large proportion of the aging population. There is evidence that brain tissue in patients with AD is exposed to oxidative stress during the course of the disease. Conessine is a natural steroidal glycoside, which has been reported to exert various biological activities such as antioxidant and anti-inflammatory effect. Aim: The present study aimed to investigate the effects of Conessine on neurobehavioral activity and superoxide dismutase (SOD), glutathione reductase (GRx) and catalase (CAT) enzymes activity, malondialdehyde (MDA) levels in hippocampal area of rats in an experimental model of AD. Methods: The AD was induced in animals by intracerebroventricular injection of STZ (icv-STZ) unilaterally. Animals were treated with the Conessine (20 mg/kg body weight), then after three successive weeks, recognition memory was examined (passive avoidance test and novel object recognition test) and antioxidant parameters were evaluated. Results: In our study behavioural testes showed improvement on memory retrieval and recognition memory consolidation. Furthermore the Conessine increased the activity of antioxidant enzymes SOD, glutathione GRx and CAT levels and decreased MDA in the hippocampal area. Conclusion: These results suggested that Conessine may inhibit STZ-induced oxidative stress, and that it may possess therapeutic potential for the treatment of AD.
Cite this article:
Nagaraju Bandaru, Chandrasekhar Komavari, Uma Sankar Gorla, GSN Koteswarao, Umasankar Kulandaivelu, A. Ankarao. Neuroprotective effect of Conessinin on Elevated oxidative stress induced Alzheimers’disease in rats. Research J. Pharm. and Tech 2020; 13(6): 2703-2707. doi: 10.5958/0974-360X.2020.00481.3
Cite(Electronic):
Nagaraju Bandaru, Chandrasekhar Komavari, Uma Sankar Gorla, GSN Koteswarao, Umasankar Kulandaivelu, A. Ankarao. Neuroprotective effect of Conessinin on Elevated oxidative stress induced Alzheimers’disease in rats. Research J. Pharm. and Tech 2020; 13(6): 2703-2707. doi: 10.5958/0974-360X.2020.00481.3 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-6-31
REFERENCES:
1. M.O. Grimm, L. Regner, J. Mett, C.P. Stahlmann, P. Schorr, C. Nelke, O. Streidenberger, H. Stoetzel, J. Winkler, S.R. Zaidan, A. Thiel, Tocotrienol affects oxidative stress, cholesterol homeostasis and the amyloidogenic pathway in neuroblastoma cells: consequences for Alzheimer’s disease, Int. J. Mol. Sci. 17 (2016) 1809.
2. Z. Cai, C. Wang, W. Yang, Role of berberine in Alzheimer’s disease, Neuropsychiatr. Dis. Treat. 12 (2016) 2509.
3. A. Demuro, I. Parker, G.E. Stutzmann, Calcium signaling and amyloid toxicity in Alzheimer disease, J. Biol. C 10 (2008) 231–239. T.D. Bird, Genetic aspects of Alzheimer disease, Genet. Med.
4. K. Jomova, D. Vondrakova, M. Lawson, M. Valko, Metals, oxidative stress and neurodegenerative disorders, Mol. Cell. Biochem. 345 (2010) 91–104.
5. A.D. Plowey, J.L. Ziskin, Hippocampal phospho-tau/MAPT neuropathology in the fornix in Alzheimer disease: an immunohistochemical autopsy study, Acta Neuropathol. Commun. 4 (2016) 114.
6. T.H. Ferreira-Vieira, I.M. Guimaraes, F.R. Silva, F.M. Ribeiro, Alzheimer's disease: targeting the cholinergic system, Curr. Mol. Pharmacol. 14 (2016) 101–115.
7. S. Manoharan, G.J. Guillemin, R.S. Abiramasundari, M.M. Essa, M. Akbar, M.D. Akbar, The role of reactive oxygen species in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a mini review, Oxid. Med. Cell. 2016 (2016).
8. E.H. Verbon, J.A. Post, J. Boonstra, The influence of reactive oxygen species on cell cycle progression in mammalian cells, Gene. 511 (2012) 1–6.
9. A.Cimini, R. Gentile, B. D'Angelo, E. Benedetti, L. Cristiano, M.L. Avantaggiati, A. Giordano, C. Ferri, G. Desideri, Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer's disease model by modulating BDNF signaling pathway, J. Cell. Biochem. 114 (2013) 2209–2220.
10. Duez, P; Chamart, S; Lejoly, J; Hanocq, M; Zeba, B; Sawadogo, M; Guissou, P; Molle, L (1987). "Changes in conessine in stem bark of Holarrhena floribunda in Burkina Faso". Annales pharmaceutiques françaises.45(4):307–13.
11. R. Lashgari, F. Motamedi, S.Z. Asl, S. Shahidi, A. Komaki, Behavioral and electrophysiological studies of chronic oral administration of L-type calcium channel blocker verapamil on learning and memory in rats, Behav. Brain Res. 171 (2006) 324–328.
12. Bejar C, Wang RH, Weinstock M. Effect of rivastigmine on scopolamine induced memory impairment in rats. Eur J Pharmacol 1999; 383:231 40.
13. S. Genet, R.K. Kale, N.Z. Baquer, Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonella foenum graecum), Mol. Cell. Biochem. 236 (2002) 7–12.
14. R.E. Pinto, W. Bartley, The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates, Biochem. J. 112 (1969) 109–115.
15. H. Esterbauer, K.H. Cheeseman, Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal, Methods Enzymol. 186 (1990) 407–421.
16. F. Donato, M.G. de Gomes, A.T.R. Goes, C. Borges Filho, L. Del Fabbro, M.S. Antunes, L.C. Souza, S.P. Boeira, C.R. Jesse, Hesperidin exerts antidepressantlike effects in acute and chronic treatments in mice: possible role of L-arginine-NOcGMP pathway and BDNF levels, Brain Res. Bull. 104 (2014) 19–26.
17. V. Gaur, A. Kumar, Hesperidin pre-treatment attenuates NO-mediated cerebral ischemic reperfusion injury and memory dysfunction, Pharmacol. Rep. 62 (2010) 635–648.
18. A.Gella, N. Durany, Oxidative stress in Alzheimer disease, Cell. Adh. Migr. 3 (2009) 88–93.
19. N. Kaneai, M. Arai, H. Takatsu, K. Fukui, S. Urano, Vitamin E inhibits oxidative stress-induced denaturation of nerve terminal proteins involved in neurotransmission, J. Alzheimer Dis. 28 (2012) 183–189.
20. Z.M.A.L. Rubaei, T.U. Mohammad, L.K. Ali, Effects of local curcumin on oxidative stress and total antioxidant capacity in vivo study, Pak. J. Biol. Sci. 17 (2014) 1237–1241.
21. C.B. Pocernich, D.A. Butterfield, Elevation of glutathione as a therapeutic strategy in Alzheimer disease, Biochim. Biophys. Acta 1822 (2012) 625–630.
22. S. Saharan, P.K. Mandal, The emerging role of glutathione in Alzheimer's disease, J. Alzheimers Dis. 40 (2014) 519–529.